We would love to hear your thoughts about our site and services, please take our survey here.
Rampers LOL .... :)
Remarkable trial results from Avacta's tumor targeting drug
https://www.outsourcing-pharma.com/Article/2023/06/22/remarkable-trial-results-from-avacta-s-tumor-targeting-drug
Avacta on ‘verge of a paradigm shift in how chemotherapy is delivered to cancer patients
https://ukinvestormagazine.co.uk/avacta-on-verge-of-a-paradigm-shift-in-how-chemotherapy-is-delivered-to-cancer-patients-shares-surge/
Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/0edad695-bd3b-40cb-8584-55815a4c98c1
( interesting statement ring a bell ? )
He said the deal’s real value lies in the pipeline of drugs earlier in development, which are trying to improve on the market leaders by making them more lethal to cancer cells but safer to administer.
https://www.ft.com/content/0edad695-bd3b-40cb-8584-55815a4c98c1